Literature DB >> 21871677

Impact of rheumatic diseases and chronic joint symptoms on quality of life in the elderly.

Gláucia Regina Falsarella1, Ibsen Bellini Coimbra, Anita Liberalesso Neri, Caroline Coutinho Barcelos, Lílian Tereza Lavras Costallat, Olga Maria Fernandes Carvalho, Arlete Maria Valente Coimbra.   

Abstract

Musculoskeletal disorders are the major causes of the pain in the elderly population. Rheumatic conditions restrict participation in activities and mobility, as well as cause difficulties in the execution of self-care tasks. The assessment of health related quality of life (HRQOL) is an important indicator of the impact of rheumatic diseases on the physical, mental and social aspects. This study aims to analyze the influence of rheumatic diseases and chronic joint symptoms on the quality of life of the elderly (n=2209) aged 60 years or over. The effects of rheumatism and joint symptoms on quality of life were investigated by the Outcome Study Short-Form Health Survey (SF-36), and this analysis was adjusted for age and sex. The univariate analysis of variance and analysis of covariance (ANOVA and ANCOVAS) were used for statistical procedures, p≤0.05. Rheumatic diseases affected: functional capacity (F(1, 2012))=10.9 and pain (F(1, 2012))=34.77. Joint symptoms affected all components of the SF-36: physical functioning (F(1, 2012))=10.9; physical problems (F(1, 2012))=72.61; pain (F(1, 2012))=164.29; general health (F(1, 2012))=71.95; vitality (F(1, 2012))=55.78; social aspect (F(1, 2012))=73.14; emotional aspect (F(1, 2012))=49.09 and mental health (F(1, 2012))=44.72. There was a significant impact of rheumatic diseases on physical health, and that joint symptoms affected self-evaluations of physical and mental health. These results will contribute to a better understanding of this systemic disease and will be used for planning effective interventions. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21871677     DOI: 10.1016/j.archger.2011.06.038

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  6 in total

1.  Cross-cultural evaluation of the French version of the LEIPAD, a health-related quality of life instrument for use in the elderly living at home.

Authors:  I Jalenques; C Auclair; J Roblin; D Morand; R Tourtauchaux; R May; E Vaille-Perret; J Watts; L Gerbaud; D De Leo
Journal:  Qual Life Res       Date:  2012-04-03       Impact factor: 4.147

2.  A stiff price to pay: does joint stiffness predict disability in an older population?

Authors:  Manu Thakral; Ling Shi; Robert H Shmerling; Jonathan F Bean; Suzanne G Leveille
Journal:  J Am Geriatr Soc       Date:  2014-10       Impact factor: 5.562

3.  An early intervention program for subacute physical disability related to musculoskeletal diseases in the elderly: a pilot study.

Authors:  Lydia Abasolo; Leticia Leon; Cristina Lajas; Loreto Carmona; Jose Antonio Serra; Agustín Reoyo; Luis Rodriguez-Rodriguez; Juan Ángel Jover
Journal:  Rheumatol Int       Date:  2015-01-30       Impact factor: 2.631

4.  Predictors of impaired quality of life in patients with rheumatic diseases.

Authors:  Panagiota Anyfanti; Areti Triantafyllou; Panagiotis Panagopoulos; Georgios Triantafyllou; Athina Pyrpasopoulou; Sophia Chatzimichailidou; Nikolaos Koletsos; Ioannis Botis; Spyros Aslanidis; Stella Douma
Journal:  Clin Rheumatol       Date:  2015-12-23       Impact factor: 2.980

5.  The effects of integrative in-patient treatment on patients' quality of life: a meta-analysis.

Authors:  Thomas Ostermann; Jost Langhorst; Andre-Michael Beer
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-28       Impact factor: 2.629

6.  Quality of life in rehabilitation outpatients: normal values and a comparison with the general Dutch population and psychiatric patients.

Authors:  Ernst Schrier; Irene Schrier; Jan H B Geertzen; Pieter U Dijkstra
Journal:  Qual Life Res       Date:  2015-07-10       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.